Quantitative Analysis of Prostate MRI: Correlation between Contrast-Enhanced Magnetic Resonance Fingerprinting and Dynamic Contrast-Enhanced MRI Parameters

被引:1
作者
Choi, Moon-Hyung [1 ]
Lee, Young-Joon [1 ]
Han, Dongyeob [2 ]
Kim, Dong-Hyun [3 ]
机构
[1] Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Dept Radiol, Seoul 03312, South Korea
[2] Siemens Healthineers Ltd, Seoul 06620, South Korea
[3] Yonsei Univ, Sch Elect & Elect Engn, Seoul 03722, South Korea
关键词
magnetic resonance fingerprinting; dynamic contrast-enhanced magnetic resonance imaging; quantitative analysis; prostate; prostate neoplasm; MULTIPARAMETRIC MRI; CANCER; DIFFERENTIATION; HYPERPLASIA;
D O I
10.3390/curroncol30120750
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This research aimed to assess the relationship between contrast-enhanced (CE) magnetic resonance fingerprinting (MRF) values and dynamic contrast-enhanced (DCE) MRI parameters including (K-trans, K-ep, V-e, and iAUC). To evaluate the correlation between the MRF-derived values (T1 and T2 values, CE T1 and T2 values, T1 and T2 change) and DCE-MRI parameters and the differences in the parameters between prostate cancer and noncancer lesions in 68 patients, two radiologists independently drew regions-of-interest (ROIs) at the focal prostate lesions. Prostate cancer was identified in 75% (51/68) of patients. The CE T2 value was significantly lower in prostate cancer than in noncancer lesions in the peripheral zone and transition zone. K-trans, K-ep, and iAUC were significantly higher in prostate cancer than noncancer lesions in the peripheral zone (p < 0.05), but not in the transition zone. The CE T1 value was significantly correlated with K-trans, V-e, and iAUC in prostate cancer, and the CE T2 value was correlated to V-e in noncancer. Some CE MRF values are different between prostate cancer and noncancer tissues and correlate with DCE-MRI parameters. Prostate cancer and noncancer tissues may have different characteristics regarding contrast enhancement.
引用
收藏
页码:10299 / 10310
页数:12
相关论文
共 27 条
[1]   Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2 [J].
Afshari Mirak, Sohrab ;
Mohammadian Bajgiran, Amirhossein ;
Sung, Kyunghyun ;
Asvadi, Nazanin H. ;
Markovic, Daniela ;
Felker, Ely R. ;
Lu, David ;
Sisk, Anthony ;
Reiter, Robert E. ;
Raman, Steven S. .
ABDOMINAL RADIOLOGY, 2020, 45 (07) :2225-2234
[2]   ESUR prostate MR guidelines 2012 [J].
Barentsz, Jelle O. ;
Richenberg, Jonathan ;
Clements, Richard ;
Choyke, Peter ;
Verma, Sadhna ;
Villeirs, Geert ;
Rouviere, Olivier ;
Logager, Vibeke ;
Futterer, Jurgen J. .
EUROPEAN RADIOLOGY, 2012, 22 (04) :746-757
[3]   DCE MRI of prostate cancer [J].
Berman, Rose M. ;
Brown, Anna M. ;
Chang, Silvia D. ;
Sankineni, Sandeep ;
Kadakia, Meet ;
Wood, Bradford J. ;
Pinto, Peter A. ;
Choyke, Peter L. ;
Turkbey, Baris .
ABDOMINAL RADIOLOGY, 2016, 41 (05) :844-853
[4]   Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: Evaluation of discriminant criteria at multiparametric MRI [J].
Chesnais, A. L. ;
Niaf, E. ;
Bratan, F. ;
Mege-Lechevallier, F. ;
Roche, S. ;
Rabilloud, M. ;
Colombel, M. ;
Rouviere, O. .
CLINICAL RADIOLOGY, 2013, 68 (06) :E323-E330
[5]   Optimal cut-off value of perfusion parameters for diagnosing prostate cancer and for assessing aggressiveness associated with Gleason score [J].
Cho, Eunkyung ;
Chung, Dong Jin ;
Yeo, Dong Myung ;
Sohn, Dongwan ;
Son, Yohan ;
Kim, Taejung ;
Hahn, Sung-Tae .
CLINICAL IMAGING, 2015, 39 (05) :834-840
[6]   Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization [J].
Cristel, Giulia ;
Esposito, Antonio ;
Damascelli, Anna ;
Briganti, Alberto ;
Ambrosi, Alessandro ;
Brembilla, Giorgio ;
Brunetti, Lisa ;
Antunes, Sofia ;
Freschi, Massimo ;
Montorsi, Francesco ;
Del Maschio, Alessandro ;
De Cobelli, Francesco .
EUROPEAN JOURNAL OF RADIOLOGY, 2019, 118 :51-57
[7]  
Cuenod C A, 2013, Diagn Interv Imaging, V94, P1187, DOI 10.1016/j.diii.2013.10.010
[8]   Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience [J].
Di Campli, Eleonora ;
Pizzi, Andrea Delli ;
Seccia, Barbara ;
Cianci, Roberta ;
d'Annibale, Martina ;
Colasante, Antonella ;
Cinalli, Sebastiano ;
Castellan, Pietro ;
Navarra, Riccardo ;
Iantorno, Romina ;
Gabrielli, Daniela ;
Buffone, Angelica ;
Caulo, Massimo ;
Basilico, Raffaella .
EUROPEAN JOURNAL OF RADIOLOGY, 2018, 101 :17-23
[9]   Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer [J].
Franiel, Tobias ;
Hamm, Bernd ;
Hricak, Hedvig .
EUROPEAN RADIOLOGY, 2011, 21 (03) :616-626
[10]   Feasibility of Novel Three-Dimensional Magnetic Resonance Fingerprinting of the Prostate Gland: Phantom and Clinical Studies [J].
Han, Dongyeob ;
Choi, Moon Hyung ;
Lee, Young Joon ;
Kim, Dong Hyun .
KOREAN JOURNAL OF RADIOLOGY, 2021, 22 (08) :1332-1340